294 related articles for article (PubMed ID: 30721781)
1. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Acosta LF; Galuppo R; García CR; Villacorta E; Dugan A; Castellanos AL; Gedaly R; Lee JT
J Surg Res; 2019 Jun; 238():10-15. PubMed ID: 30721781
[TBL] [Abstract][Full Text] [Related]
2. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.
Montano-Loza AJ; Meza-Junco J; Baracos VE; Prado CM; Ma M; Meeberg G; Beaumont C; Tandon P; Esfandiari N; Sawyer MB; Kneteman N
Liver Transpl; 2014 Jun; 20(6):640-8. PubMed ID: 24678005
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
5. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
Varona MA; Soriano A; Aguirre-Jaime A; Garrido S; Oton E; Diaz D; Portero J; Bravo P; Barrera MA; Perera A
Transplant Proc; 2015; 47(1):84-9. PubMed ID: 25645778
[TBL] [Abstract][Full Text] [Related]
7. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients.
Sharma P; Parikh ND; Yu J; Barman P; Derstine BA; Sonnenday CJ; Wang SC; Su GL
Liver Transpl; 2016 Aug; 22(8):1092-8. PubMed ID: 27064263
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation.
Kim Y; Park YH; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Lee SG
Ann Transplant; 2016 Oct; 21():660-667. PubMed ID: 27777395
[TBL] [Abstract][Full Text] [Related]
11. Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection.
Polvieng T; Hongjinda S; Thienhiran A; Burasakarn P; Fuengfoo P
Am Surg; 2024 Jun; 90(6):1447-1455. PubMed ID: 38516765
[TBL] [Abstract][Full Text] [Related]
12. Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor.
Vibert E; Azoulay D; Hoti E; Iacopinelli S; Samuel D; Salloum C; Lemoine A; Bismuth H; Castaing D; Adam R
Am J Transplant; 2010 Jan; 10(1):129-37. PubMed ID: 20070666
[TBL] [Abstract][Full Text] [Related]
13. Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria.
Beumer BR; van Vugt JLA; Sapisochin G; Yoon P; Bongini M; Lu D; Xu X; De Simone P; Pintore L; Golse N; Nowosad M; Bennet W; Tsochatzis E; Koutli E; Abbassi F; Claasen MPAW; Merli M; O'Rourke J; Gambato M; Benito A; Majumdar A; Tan EK; Ebadi M; Montano-Loza AJ; Berenguer M; Metselaar HJ; Polak WG; Mazzaferro V; IJzermans JNM;
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2373-2382. PubMed ID: 36622940
[TBL] [Abstract][Full Text] [Related]
14. Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma.
Hamaguchi Y; Kaido T; Okumura S; Ito T; Fujimoto Y; Ogawa K; Mori A; Hammad A; Hatano E; Uemoto S
J Hepatobiliary Pancreat Sci; 2015 Jun; 22(6):475-85. PubMed ID: 25755128
[TBL] [Abstract][Full Text] [Related]
15. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation.
Golse N; Bucur PO; Ciacio O; Pittau G; Sa Cunha A; Adam R; Castaing D; Antonini T; Coilly A; Samuel D; Cherqui D; Vibert E
Liver Transpl; 2017 Feb; 23(2):143-154. PubMed ID: 28061014
[TBL] [Abstract][Full Text] [Related]
16. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
[TBL] [Abstract][Full Text] [Related]
17. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L
Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857
[TBL] [Abstract][Full Text] [Related]
18. Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
Giard JM; Mehta N; Dodge JL; Roberts JP; Yao FY
Transplantation; 2018 May; 102(5):816-822. PubMed ID: 29505494
[TBL] [Abstract][Full Text] [Related]
19. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee HW; Song GW; Lee SG; Kim JM; Joh JW; Han DH; Kim SI; Kim SH; Kim DS; Cho JY; Suh KS
Liver Transpl; 2018 Sep; 24(9):1243-1251. PubMed ID: 29575509
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
